
Opinion|Videos|July 16, 2024
Treatment Options and Management of Neurofibromatosis Type 1 Related Plexiform Neurofibroma
Author(s)Kaleb H. Yohay, MD
A key opinion leader offers a comprehensive overview of neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN), detailing its symptoms, clinical manifestations, prevalence, and impact on patients' quality of life.
Advertisement
Episodes in this series

- Can you provide an overview of the available management options for NF1-PN and when various options are utilized (observation, surgery, MEK inhibitors, investigational therapies)?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
POLARIS-AD Phase 3 Trial of PDE5 Inhibitor AR1001 Completes Treatment Phase With Favorable Safety Profile
2
Focused Ultrasound vs DBS for Parkinson Disease: What New Bilateral Data Tell Us
3
FDA Approves At-Home Starting Dose for Lecanemab, Marking First Subcutaneous Initiation Option for Alzheimer Disease Treatment
4
Novel Anti-Tau Seeding Antibody MK-2214 Achieves Near-Complete CSF Target Engagement in Phase 1
5


















